JCRB0824 8305C
Cell information
Cell type:general cells (View Pricing Information)
JCRB No. | JCRB0824 | Cell Name | 8305C |
---|---|---|---|
Profile | Human undifferentiated thyroid carcinoma with C:G->T:A mutation at codon 273 of p53 gene. | Other Name | 5-C-O |
Animal | human | Strain | |
Genus | Homo | Species | sapiens |
Sex | F | Age | 67 |
Identity | available | Tissue for Primary Cancer | thyroid |
Case history | undifferentiated thyroid carcinoma | Metastasis | No |
Tissue Metastasized | Genetics | C:G->T:A mutation at codon 273 of p53 gene | |
Life Span | infinite | Crisis PDL | |
Morphology | fibroblast-like | Character | thyroid anaplastic carcinoma, undifferentiated |
Classify | tumor | Established by | Hiraoka,T. et al. |
Registered by | Akiyama,M. | Regulation for Distribution | |
Comment | Year | 1987 | |
Medium | Eagle's minimal essential medium with 10% fetal calf serum | Methods for Passages | 0.25% trypsin and dilute in fresh medium. Change medium twice a week |
Cell Number on Passage | split ratio=1/6 | Race | |
CO2 Conc. | 5 % | Tissue Sampling | thyroid |
Tissue Type |
Detection of virus genome fragment by Real-time PCR | |||||||||
---|---|---|---|---|---|---|---|---|---|
Detected DNA Virus | tested | Detected RNA Virus | tested | ||||||
CMV | - | parvoB19 | - | HCV | - | HTLV-1 | - | ||
EBV | - | HBV | - | HIV-1 | - | HTLV-2 | - | ||
HHV6 | - | HTLV-1 | - | HIV-2 | - | HAV | - | ||
HHV7 | - | HTLV-2 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
BKV | - | HIV-1 | - | ||||||
JCV | - | HIV-2 | - | ||||||
ADV | - | HPV18 | - | ||||||
Notes |
Reference | |
---|---|
Pubmed id:21566963 | Establishment of 2 human thyroid-carcinoma cell-lines (8305c, 8505c) bearing p53 gene-mutations. Ito T,Seyama T,Hayashi Y,Hayashi T,Dohi K,Mizuno T,Iwamoto K,Tsuyama N,Nakamura N,Akiyama M Int J Oncol. 1994 Mar;4(3):583-6 |
Pubmed id:1737400 | Unique association of p53 mutations with undifferentiated but not with differentiated carcinomas of the thyroid gland. Ito T,Seyama T,Mizuno T,Tsuyama N,Hayashi T,Hayashi Y,Dohi K,Nakamura N,Akiyama M Cancer Res. 1992 Mar 1;52(5):1369-71 |
Images |
---|
Movies |
---|
LOT Information
Cell No. | JCRB0824 | Cell Name | |
---|---|---|---|
LOT No. | 07252003 | Lot Specification | distribution |
Medium | Eagle's minimal essential medium with 10% fetal bovine serum (FBS lot; GIBCO 3762782S) | Temperature | 37 C |
Cell Density at Seeding | 3-6 x 10^4 cells/ml | Methods for Passages | 0.25% trypsin and 0.02% EDTA |
Doubling Time | D.T. = ca. 50 hrs | Cell Number in Vial (cells/1ml) | 9.0 x 10^5 |
Viability at cell freezing (%) | 83 | Antibiotics Used | free |
Passage Number | P35 | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), AST. |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Yes | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - EMEM | CO2 Conc. | 5% |
Viability immediately after thawing (%) | Additional information |
Cell No. | JCRB0824 | Cell Name | |
---|---|---|---|
LOT No. | 090495 | Lot Specification | distribution |
Medium | Eagle's minimal essential medium with 10% fetal calf serum | Temperature | 37 |
Cell Density at Seeding | Methods for Passages | 0.25% trypsin and dilute in fresh medium. Change medium twice a week | |
Doubling Time | Cell Number in Vial (cells/1ml) | ||
Viability at cell freezing (%) | Antibiotics Used | ||
Passage Number | PDL | ||
Sterility: MYCOPLASMA | Sterility: BACTERIA | ||
Sterility: FUNGI | Isozyme Analysis | ||
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Exoteric Gene | ||
Medium for Freezing | CO2 Conc. | ||
Viability immediately after thawing (%) | Additional information |
Cell No. | JCRB0824 | Cell Name | |
---|---|---|---|
LOT No. | 091195 | Lot Specification | distribution |
Medium | Eagle's minimal essential medium with 10% fetal calf serum | Temperature | 37 |
Cell Density at Seeding | Methods for Passages | 0.25% trypsin and dilute in fresh medium. Change medium twice a week | |
Doubling Time | Cell Number in Vial (cells/1ml) | ||
Viability at cell freezing (%) | Antibiotics Used | ||
Passage Number | PDL | ||
Sterility: MYCOPLASMA | Sterility: BACTERIA | ||
Sterility: FUNGI | Isozyme Analysis | ||
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Exoteric Gene | ||
Medium for Freezing | CO2 Conc. | ||
Viability immediately after thawing (%) | Additional information |
Cell No. | JCRB0824 | Cell Name | 8305C |
---|---|---|---|
LOT No. | 05302014 | Lot Specification | distribution |
Medium | Eagle's minimum essential medium with 10% fetal bovine serum (FBS; GIBCO Cat. # 10091) | Temperature | 37 C |
Cell Density at Seeding | 3.7 - 8.3 x 10^4 cells/mL | Methods for Passages | Cells were harvested after treatment with 0.25% trypsin and 0.02% EDTA. |
Doubling Time | Cell Number in Vial (cells/1ml) | 1.2 x 10^6 | |
Viability at cell freezing (%) | 86 | Antibiotics Used | free |
Passage Number | P40 | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), MD. |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | D5S818:10,13 D13S317:9 D7S820:8,10 D16S539:10,11 VWA:14,16 TH01:6,7 AM:X TPOX:8 CSF1PO:9,12 |
|
Adhesion | Yes | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - EMEM | CO2 Conc. | 5% |
Viability immediately after thawing (%) | 86 | Additional information |